Development of Acridone Derivatives: Targeting c-MYC Transcription in Triple-Negative Breast Cancer with Inhibitory Potential
Breast cancer, especially the aggressive triple-negative subtype, poses a serious health threat to women.Unfortunately, effective targets are lacking, leading to a grim prognosis.Research highlights the crucial role of c-MYC overexpression in this form of cancer.Current Pullover Hoodie inhibitors targeting c-MYC focus on stabilizing its G-quadruple